Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Aclaris Therapeutics Inc (ACRS)

  • Event
  • June 03, 2022, 21:15 UTC
  • 9
  • 1 comments

(99% Neutral) Aclaris Therapeutics, Inc. (ACRS) Announces Regulatory Update

Comment Full text

Harpoon Therapeutics Inc (was acquisited by Merck (NYSE:MRK) on 11/03/2024) (HARP)

  • Event
  • June 03, 2022, 21:05 UTC
  • 9
  • 1 comments

(70% Positive) Harpoon Therapeutics, Inc. (HARP) Announces Clinical Development Update

Comment Full text

Selecta Biosciences Inc (SELB)

  • Event
  • June 03, 2022, 20:30 UTC
  • 11
  • 1 comments

(99% Neutral) SELECTA BIOSCIENCES, INC. (SELB) Files Form 8-K

Comment Full text

Sarepta Therapeutics Inc (SRPT)

  • Event
  • June 03, 2022, 20:20 UTC
  • 10
  • 1 comments

(99% Neutral) Sarepta Therapeutics, Inc. (SRPT) Announces New Board Appointment

Comment Full text

Verrica Pharmaceuticals (VRCA)

  • Event
  • June 03, 2022, 20:16 UTC
  • 11
  • 1 comments

(99% Neutral) Verrica Pharmaceuticals Inc. (VRCA) Files Form 8-K

Comment Full text

Rain Therapeutics Inc (was acquired by Pathos AI, Inc. (“Pathos”) on 13/12/2023) (RAIN)

  • Event
  • June 03, 2022, 20:10 UTC
  • 11
  • 1 comments

(99% Neutral) Rain Therapeutics Inc. (RAIN) Files Form 8-K

Comment Full text

Ironwood Pharmaceuticals Inc (IRWD)

  • Event
  • June 03, 2022, 20:05 UTC
  • 11
  • 1 comments

(99% Neutral) IRONWOOD PHARMACEUTICALS, INC. (IRWD) Announces Regulatory Update

Comment Full text

Denali Therapeutics (DNLI)

  • Event
  • June 03, 2022, 20:01 UTC
  • 11
  • 1 comments

(99% Neutral) Denali Therapeutics Inc. (DNLI) Announces Regulatory Update

Comment Full text

Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX)

  • Event
  • June 03, 2022, 13:00 UTC
  • 11
  • 1 comments

(19% Negative) TURNING POINT THERAPEUTICS, INC. (TPTX) Announces Business Combination

Comment Full text

Replimune Group Inc (REPL)

  • Event
  • June 03, 2022, 12:10 UTC
  • 11
  • 1 comments

(99% Neutral) REPLIMUNE GROUP, INC. (REPL) Provides Update on announced for a variety of cancer types

Comment Full text
  • Previous
  • 196
  • 197
  • 198
  • 199
  • 200
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2261)
  • SEC News(189391)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124578)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin